Search results

1. Mr Oscar Baldwin

   ... disease and its rarity. My work aims at understanding the events that allow the normal developing choroid plexus epithelium to transform ...

2. Dr Saif Ahmad

   I am a senior clinical oncology trainee currently undertaking a Clinical PhD Fellowship at the MRC Cancer Unit in Prof Ashok Venkitaraman's lab. My research is focused on understanding a novel mechanism by which the BRCA2 tumour suppressor protein...

3. Dr Sujath Abbas

   ... (OAC), where I investigated the dynamics of mutational events during the development and spread of OAC. Also, along with colleagues I ...

4. Professor Walid Khaled

   ... works on defining the early cellular and molecular events that drive tumour initiation and development. In particular, we focus on ...

5. Dr David Gilligan

   David Gilligan is a Consultant Clinical Oncologist at Addenbrooke's and Papworth Hospitals in Cambridge. He is the Clinical Lead for Acute Oncology at Addenbrooke's. He trained in pre clinical medicine at the University of Edinburgh and clinical...

6. Mr David Thurtle

   Radiological assessment of prostatic osseous metastases. Robotic-assisted laparoscopic prostatectomy. Early detection of prostate cancer. Risk Prediction in prostate cancer

7. Dr Roisin Owens

   Our group works on integrating biological models with electronic devices to generate systems that can be predictive of real biological systems, for drug discovery and therapeutics. We combine expertise in a wide range of disciplines including...

8. Mr Thierry Lefebvre

   Radiotherapy is often prescribed in oncology clinics to treat solid tumours and to limit the development and the propagation of cancer cells. The lack of oxygenation seen in some tumour regions under chaotic and unrestricted cellular growth constitute a...

9. Dr Anita Chandra

10. Dr Amy Riddell

11. Mr Angelos Kolias

    Angelos Kolias is a Clinical Senior Lecturer and Consultant Neurosurgeon in the Department of Clinical Neurosciences, Addenbrooke’s Hospital and University of Cambridge, Cambridge, UK. He also holds an adjunct Professorship at Humanitas University,...

12. Dr Anne-Laure Vallier

    (tbc)

13. Professor Tony Green

    Tony Green is Professor of Haemato-oncology in the University of Cambridge and honorary Consultant Haematologist at Addenbrookes Hospital. He was appointed Head of the University Department of Haematology (2000-2020), and in 2016 was appointed Director...

14. Dr Alex Samoshkin

    I have been a Translational Technology Manager in the University of Cambridge since 2017. My primary role is to connect researchers in technology/physical sciences with clinicians and academics to develop new collaborative translational projects. I...

15. Dr Emma Beddowes

    Investigating the development and application of circulating free nucleic acids to breast cancer research.

16. Mrs Bin Liu

    Clinical information system

17. Dr Chiwen Chang

    1. Interaction between NK cells and HLA Class I antigen during immune response. 2. Immunotherapy for cancers and autoimmune diseases.

18. Dr Callum Campbell

19. Mr Arqum Anwar

    Rotation Project: The project aims to investigate the cellular role(s) of a novel factor expected to be involved in DNA damage response. Specifically, the interactome of the protein will be explored using co-immunoprecipitation followed by mass...

20. Dr Andreas Bender

    Previously affiliated with the Lead Discovery Informatics (LDI) group of Novartis in Cambridge/MA, I am now developing and applying cheminformatics techniques in the drug discovery field in my group with the University of Cambridge. Our expertise ranges...

21. Professor Alan Warren

    Our long-term goal is to elucidate the molecular mechanisms of ribosome assembly in eukaryotic cells and to understand how defects in this process cause bone marrow failure and cancer predisposition. Assembly of the two subunits of the ribosome,...

22. Dr Alasdair Russell

    Alasdair heads up a specialised team that provide a centralised ‘Hub’ for the innovation and application of state-of-the-art Genome Editing technologies to complex, patient-relevant model systems in a pre-clinical setting. Further, we use these novel...

23. Dr Alexey Larionov

    Hormonal treatment and resistance in Breast cancer Heritable cancer predisposition NGS data analysis

24. Dr Andrew Bannister

    I have spent the last three decades generally messing around with chromatin with a special focus on histones and their modifications. My research has focused on identifying novel histone modifications together with characterization of the enzymes ...

25. Dr Antony Rix

    Co-founded by Prof Evis Sala and Dr Antony Rix, Lucida Medical is a spin-out from the University of Cambridge Department of Radiology and Cambridge University Hospitals. The company develops AI-based software to help automate the analysis of...

26. Professor Anthony Davenport

    Our research group focuses on understanding the role of G-protein-coupled receptors (GPCRs, targets for about ~50% of current drugs) together with their transmitters in humans. We use in vitro pharmacology and in vivo imaging using positron emission...

27. Dr Alex Cagan

    My research seeks  to understand the somatic evolutionary processes that occur within our bodies as we age and their consequences for health.  Evolution is often considered  to be an almost imperceptibly slow process. However, the cells that...

28. Dr Andre Neves

    As a chemical engineer, I enjoy translating basic science into novel biomedical technologies. I am interested in the use of molecular imaging techniques for early cancer diagnosis and for better assessing response to cancer therapy. Currently, I'm...

29. Dr Adrien Hallou

    Initially trained as a physicist and a chemist at the Ecole Normale Supérieure (Paris, France), I developed my interest for quantitative approaches of biological systems during my MPhil and PhD in Biophysics at the University of Cambridge. I am now a...

30. Mr Amit Roshan

    ... focus is currently exploring the utility of circulating tumour DNA (ctDNA) in early melanoma, and progressing our understanding of ...

31. Dr Andrew Gill

    I work in the hyperpolarized-13C imaging group in the Department of Radiology and apply computational methods to the analysis of MR images of tumours. I have in the past specialised in pharmacokinetic modelling of DCE-MRI data. My more recent work...

32. Dr Anna Piskorz

    ... of treatment. In my research I use variety of specimens like tumour tissue and body fluids (blood, plasma, ascites). I have a special ... for copy number alterations detection, alternative tumour tissue fixative methods (UMFIX vs. NBF) and detection of mutant DNA in ...

33. Dr Athena Matakidou

    ... models will allow in-vivo investigations of the underlying tumour biology and the discovery of new methodologies for the detection, ...

34. Dr Mariann Bienz

    ... cancers are due to inactivating mutations of the APC tumour suppressor, or to activating mutations in beta-catenin, a key effector ...

35. Professor Kevin Brindle

    ... responses to an anti-vascular drug and for detecting early tumour responses to immunotherapy. An early apoptotic response following ... spectroscopy (MRS) methods for the non-invasive detection of tumour cell death in vivo. ...

36. Dr Claudia Ribeiro de Almeida

    ... class of RBPs involved in remodelling RNA secondary structure and ribonucleoprotein complexes. We have found the RNA helicase DDX1 ...

37. Professor Charlotte Coles

    Charlotte Coles is Professor of Breast Cancer Clinical Oncology and NIHR Research Professor at the CRUK Cambridge Centre. Her research aims are to provide breast cancer patients with the best chance of cure with least side effects by personalising...

38. Dr Darerca Owen

    Our work focuses on the relationship between structure and function in small G proteins and their effectors and regulators. ...

39. Dr Daniel Hodson

    Pathogenesis of Germinal Centre Derived B Cell Lymphomas. Many of the commonest human lymphomas (including follicular, diffuse large B cell and Burkitt lymphomas) develop from a specific stage of B lymphocyte differentiation termed the Germinal Centre. ...

40. Professor Ernest Laue

    The study of the structure and function of protein complexes, mainly using either NMR ... interested in the control of gene expression via chromatin structure. At the same time we are developing new NMR methods, in particular ... to extend the scope of NMR spectroscopy for the study of the structure of larger macromolecules and their interactions. We are increasingly ...

41. Dr George Follows

    ... research focuses on transcriptional regulation and chromatin structure. I maintain a supervisory role for a research assistant in Professor ...

42. Professor Gillian Murphy

    ... and growth factors and have generated information on their structure function relationships that are key to the understanding of their ...

43. Dr Julian Sale

    ... replication of both damaged bases and a particular secondary structure called the G quadruplex. Although TLS is potentially mutagenic it ...

44. Dr Jon Houseley

    ... non-coding RNAs -Histone modifications and chromatin structure -Replication and recombination Overall, we ask how cells process ...

45. Dr Lori Passmore

    We use a hybrid approach to study the structure and function of multi-protein complexes. A major focus of the lab is ... 1MDa Ccr4-Not complex and Pan2-Pan3. By understanding the structure and mechanisms of these protein complexes, we will gain insight into ...

46. Dr Ahsan MEMON

    ... cell behaviours through cell signaling. Ever since, these findings have directly led to expanding and redefining understanding of ... modulator to generate multi-depth multi-chromatic holograms. These holograms are produced through a custom-developed iterative code with ...

47. Dr Adrian Ionescu

    ... up a strong track record with international recognition in these research areas, with 50 publications and two books to date. With some of these publications I have helped shape the new interdisciplinary field of ...

48. Professor Andrew Flewitt

    ... thin film piezoelectrics. There are two applications of these. Surface acoustic wave (SAW) devices can be used to make microfluidic ...

49. Professor Anna Philpott

    ... a disease of differentiation. Ultimately, our studies on these fundamental mechanisms that co-ordinate proliferation and differentiation ...

50. Professor Ben Simons

    ... epidermal maintenance in mouse. Currently, we are extending these ideas to explore cell fate in human epidermis addressing both normal and malignant tissue. These investigations are pursued in close collaboration with experimentalists ...

51. Dr Basma Greef

    ... of hypoxia response pathways in renal cancer and how these can be harnessed to develop new treatments. My other interests include ...

52. Dr Alejandra Bruna

    ... pathway signature in ER-/basal human breast cancer. We are now focusing on trying to unravel the underlying molecular mechanisms of ...

53. Professor Antonis Antoniou

    ... and the development of risk prediction tools which are used in clinical practice. I have a research group of 10 which focuses on ...

54. Dr Catherine Lindon

    ... end of mitosis. The Aurora kinases (Aurora A and Aurora B) are two substrates of ubiquitin-mediated proteolysis that make critical ...

55. Professor Adrian Liston

    We are focussed on understanding the biology of regulatory T cells within the ...

56. Dr Ashray Gunjur

    I am an early-career medical oncologist from Melbourne, Australia. I am broadly interested in immuno-oncology and the link between cancer and the gut microbiome, and am undertaking a PhD supervised by Dr David Adams and Dr Trevor Lawley (Wellcome...

57. Miss Amara Cañizares

58. Dr Fazlur Rahman Talukdar

    ... (IARC-WHO), France, in 2015. During this tenure, my research aimed to identify DNA methylome alterations linked to esophageal cancer within ...

59. Dr Kerstin Meyer

    ... analysis of predisposition loci: My experiments are aimed at understanding the mechanisms by which breast cancer risk loci ...

60. Dr Misha Kapushesky

    ... a universal ecosystem for bioinformatics development, aimed to reduce the chaotic clutter of inefficiency and incompatibility in ...

61. Dr Nicholas Walton

    ... currently aiding in their search for new techniques aimed at the treatment of breast cancer. ...

62. Professor Rahul Roychoudhuri

    ... providing targets for development of new therapies aimed at reversing dysfunctional immune responses in cancer. ...

63. Dr Bristi Basu

    ... Phase I, II and III clinical trials, including first-in-human and first-in-class studies. My tumour site-specific focus is in ...

64. Professor Tim Eisen

    ... where I am currently responsible for oncology trials from first in man to Phase II. ...

65. Dr Elisa Laurenti

    ... As perturbation of HSC regulatory networks drives the first steps of leukaemia, knowledge of HSC specific molecular responses will ...

66. Dr Kelly Holmes

    ... CRUK Cambridge Centre Imaging Programme Manager. Kelly has a first class degree in Biochemistry with a year in industry. She completed her ...

67. Professor Duncan Jodrell

    ... therapies and novel therapeutic combinations, including first into man (phase I) and associated studies.  My research goal is to ...

68. Dr Laura Blackburn

    ... research and held a workshop on the implementation of the first ctDNA testing services in the NHS, which were facilitating treatment ...

69. Dr Aisling Redmond

    Aisling received her undergraduate degree in Genetics from Trinity College Dublin and PhD from Dublin City University. She completed postdoctoral fellowships in the breast cancer field at the Royal College of Surgeons in Ireland and Cancer Research UK...

70. Dr David Adams

    ... data for over 200 genetically modified mouse lines per year to gain a better understanding of mammalian gene function. ...

71. Dr Joanna Baxter

    The Cambridge Blood and Stem Cell Biobank is a facility of over 6000 viable and nucleic acid samples, the majority from patients with haematological malignancy and clonal blood cell disorders; and the remainder, around 20%, from normal individuals,...

72. Mrs Eva Serrao

    Despite medical advances, pancreatic cancer still has a 5-year survival rate of less than 6%. The ideal way to improve this is to ...

73. Dr Hayley Woffendin

    After many years working as a postdoctoral research scientist (Molecular Biologist) within the University and Wellcome Trust Sanger Institute, I have been Scientific Administrator and Graduate Student Administrator with the Department of Oncology Since...

74. Dr Hannah Harrison

    Since moving into public health research around 5 years, Hannah has been involved in projects investigating risk-stratification for kidney cancer screening and follow-up. Her most rencet project, funded by CRUK, is investigating multifactorial models...

75. Dr Amos Burke

    ... and currently co-supervises a Clinical and a basic science PhD student. At a national level Dr Burke is the National Institute for Health ...

76. Miss Annalisa Occhipinti

    I am a Mathematician and I am doing a PhD in bioinformatics at the University if Cambridge. I am currently working on ...

77. Dr Cedric Ghevaert

    ... the Royal College of Pathologists in 2005. He obtained his PhD in 2008 studying novel antibodies for the treatment of bleeding in neonates ...

78. Ms Ceilidh Welsh

    I am a PhD student working with  Cancer Research UK RadNet Cambridge Radiation ...

79. Dr Danish Mazhar

    ... and Charing Cross Hospitals in London. He was awarded a PhD by Imperial College London for his research in Prostate Cancer. He has also ...

80. Dr Emmanuel Huguet

    ... undergraduate medical students. He subsequently undertook a PhD in cancer molecular biology at Oxford University in the laboratories of the ...

81. Professor Eamonn Maher

    ... and non-clinician scientists and had supervised more than 25 PhD or MD students to completion. Current research in Eamonn?s group relates to ...

Pages